# Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease

Study · id `cardio:ct-nct05203484` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05203484](<https://clinicaltrials.gov/study/NCT05203484>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05203484

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 180 participants.

## Technical summary

Registry record NCT05203484. Randomized; no masking; primary purpose treatment. Start 2022-10-01 (anticipated); primary completion 2023-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT05203484, source copy `cardio:ctgov-nct05203484-2022-08-19`, retrieved 2026-10-26)
- Planned start: 2022-10-01 (anticipated) (ClinicalTrials.gov record NCT05203484, source copy `cardio:ctgov-nct05203484-2022-08-19`, retrieved 2026-10-26)
- Primary completion: 2023-07-30 (anticipated) (ClinicalTrials.gov record NCT05203484, source copy `cardio:ctgov-nct05203484-2022-08-19`, retrieved 2026-10-26)
- Completion: 2024-07-30 (anticipated) (ClinicalTrials.gov record NCT05203484, source copy `cardio:ctgov-nct05203484-2022-08-19`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT05203484, source copy `cardio:ctgov-nct05203484-2022-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05203484-2022-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease
- Acronym: EMPIRE-VT
- Condition: Ventricular Tachycardia
- Intervention (Device): Multielecotrde Mapping
- Intervention (Device): Point-by-point mapping
- Lead sponsor: Helios Health Institute GmbH
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Helios Health Institute GmbH (`cardio:org-helios-health-institute-gmbh`)

## Provenance

Content hash: 44b724cee897a9a4085acf53fd083c6c8dee81a669b2733c9788fca3f103e4b0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
